NO974335L - Laktam-holdige hydroksaminsyrederivater, deres fremstilling og deres anvendelse som inhibitorer for matriksmetallprotease - Google Patents
Laktam-holdige hydroksaminsyrederivater, deres fremstilling og deres anvendelse som inhibitorer for matriksmetallproteaseInfo
- Publication number
- NO974335L NO974335L NO974335A NO974335A NO974335L NO 974335 L NO974335 L NO 974335L NO 974335 A NO974335 A NO 974335A NO 974335 A NO974335 A NO 974335A NO 974335 L NO974335 L NO 974335L
- Authority
- NO
- Norway
- Prior art keywords
- alkyl
- carbocycle
- heterocycle
- hydrogen
- heteroalkyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06139—Dipeptides with the first amino acid being heterocyclic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/02—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D223/06—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D223/12—Nitrogen atoms not forming part of a nitro radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Dermatology (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Den foreliggende oppfinnelse vedrører forbindelser som utviser inhiberende aktivitet mot matriks-metallproteaser ("MMP'er"). Fordi MMP'er er kjent å spille en rolle i nedbrytning av vev, kan forbindelsene ifølge den foreliggende oppfinnelse være anvendbare i forbygging eller behandling av sykdommer assosiert med overdreven MMP aktivitet. Særlig har forbindelsene en struktur i samsvar med formel (I) , hvori (A) (1) (a) R^ er hydrogen, alkyl, heteroalkyl, alkenyl, en heterocyklisk ring, en karbocyklisk ring, alkoksy, karbosyklus-alkyl, heterosyklus-alkyl, karbosyklus- heteroalkyl eller heterosyklus-heteroalkyl, og (b) R^ er hydrogen, hydroksy, alkyl, alkenyl, alkynyl, heteroalkyl, en heterocyklisk ring, en karbocyklisk ring, karbosyklus-alkyl, heterosyklus-alkyl, eller -OR hvor R er alkyl, alkenyl eller karbosyklus-alkyl, eller (2) r'- og R^ sammen danner en cykloalkylring med fra 3 til 8 ring-atomer, (B) R-' er hydrogen, alkyl eller karbosyklus-alkyl, (C) R'' er (1) alkyl, (2) karbosyklus-alkyl, (3) -X-C(=Y)-Z-R^ eller -X-CH2-Z-R^ hvor (a) X er kovalent binding eller alkyl, (b) Y er O, S eller NH, (c) Z er 0, S eller fffl, og (d) R^ er hydrogen, alkyl, alkenyl, karbosyklus-alkyl eller aryl, eller (4) -SOj-R^ hvor R^ er alkyl, karbosyklus-alkyl, heterosyklus- alkyl eller aryl, og (D) Q er - [-C (r'') j-1-¿ hvor (1) n er et helt tall 2, 3 eller 4, og (2) hver r' er uavhengig hydrogen eller alkyl slik at den Q-holdige heterosyklus er mettet. eller R''-delen på to nærliggende karbonatomer er en kovalent binding slik at den Q-holdige heterosyklus i formel (I) er umettet, eller et farmasøytisk akseptabelt salt, eller biohydrolyserbart alkoksyamid, acyloksyamid eller imid derav. Oppfinnelsen vedrører også farmasøytiske preparater omfattende disse forbindelser, og fremgangsmåter for å hindre eller behandle sykdommer
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/407,839 US5672598A (en) | 1995-03-21 | 1995-03-21 | Lactam-containing hydroxamic acids |
PCT/US1996/003726 WO1996029313A1 (en) | 1995-03-21 | 1996-03-19 | Lactam-containing hydroxamic acid derivatives, their preparation and their use as inhibitors of matrix metalloprotease |
Publications (2)
Publication Number | Publication Date |
---|---|
NO974335D0 NO974335D0 (no) | 1997-09-19 |
NO974335L true NO974335L (no) | 1997-11-21 |
Family
ID=23613737
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO974335A NO974335L (no) | 1995-03-21 | 1997-09-19 | Laktam-holdige hydroksaminsyrederivater, deres fremstilling og deres anvendelse som inhibitorer for matriksmetallprotease |
Country Status (17)
Country | Link |
---|---|
US (1) | US5672598A (no) |
EP (1) | EP0815084B1 (no) |
JP (1) | JPH11502523A (no) |
KR (1) | KR19980703151A (no) |
AR (1) | AR002718A1 (no) |
AT (1) | ATE248150T1 (no) |
AU (1) | AU711889B2 (no) |
BR (1) | BR9607772A (no) |
CA (1) | CA2216129C (no) |
CZ (1) | CZ295197A3 (no) |
DE (1) | DE69629670T2 (no) |
HU (1) | HUP9800813A3 (no) |
IL (1) | IL117527A (no) |
NO (1) | NO974335L (no) |
NZ (1) | NZ304689A (no) |
WO (1) | WO1996029313A1 (no) |
ZA (1) | ZA962253B (no) |
Families Citing this family (50)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2000516252A (ja) * | 1996-08-28 | 2000-12-05 | ザ プロクター アンド ギャンブル カンパニー | 1,4―複素環式メタロプロテアーゼ阻害剤 |
US6953788B1 (en) | 1996-09-19 | 2005-10-11 | Aventis Pharmaceuticals Inc. | 3-mercaptoacetylamino-1,5-substituted-2-oxo-azepan derivatives useful as inhibitors of matrix metalloproteinase |
CN1150205C (zh) * | 1996-09-19 | 2004-05-19 | 阿温蒂斯药物公司 | 用作基质金属蛋白酶抑制剂的3-巯基乙酰氨基-1.5-二取代的-2-氧代-氮杂环庚烷衍生物 |
PT934259E (pt) * | 1996-10-16 | 2003-01-31 | American Cyanamid Co | Acidos beta-sulfonamido hidroxamicos como inibidores de metaloproteinases de matriz e de tace |
US6174915B1 (en) | 1997-03-25 | 2001-01-16 | Agouron Pharmaceuticals, Inc. | Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses |
US20030206874A1 (en) * | 1996-11-21 | 2003-11-06 | The Proctor & Gamble Company | Promoting whole body health |
US6211235B1 (en) | 1996-11-22 | 2001-04-03 | Elan Pharmaceuticals, Inc. | Compounds for inhibiting β-amyloid peptide release and/or its synthesis |
US6191166B1 (en) | 1997-11-21 | 2001-02-20 | Elan Pharmaceuticals, Inc. | Methods and compounds for inhibiting β-amyloid peptide release and/or its synthesis |
US6683075B1 (en) | 1996-12-23 | 2004-01-27 | Athena Neurosciences, Inc. | Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use |
US6635632B1 (en) | 1996-12-23 | 2003-10-21 | Athena Neurosciences, Inc. | Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds |
US20050058709A1 (en) * | 1997-06-04 | 2005-03-17 | Fisher Gary J. | Methods for inhibiting photoaging of human skin using orally-administered agent |
US6403632B1 (en) | 2000-03-01 | 2002-06-11 | Bristol Myers Squibb Pharma Co | Lactam metalloprotease inhibitors |
ZA988967B (en) * | 1997-10-03 | 2000-04-03 | Du Pont Pharm Co | Lactam metalloprotease inhibitors. |
US6335329B1 (en) * | 1997-12-19 | 2002-01-01 | Amgen Inc. | Carboxylic acid substituted heterocycles, derivatives thereof and methods of use |
US6846478B1 (en) | 1998-02-27 | 2005-01-25 | The Procter & Gamble Company | Promoting whole body health |
US6569636B2 (en) * | 1998-05-29 | 2003-05-27 | Hawaii Biotechnology Group, Inc. | Assay for modulators of metallo-enzyme activity |
US6774125B2 (en) * | 1998-06-22 | 2004-08-10 | Elan Pharmaceuticals, Inc. | Deoxyamino acid compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds |
US6569851B1 (en) | 1998-06-22 | 2003-05-27 | Elan Pharmaceutials, Inc. | Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds |
US6528505B1 (en) | 1998-06-22 | 2003-03-04 | Elan Pharmaceuticals, Inc. | Cyclic amino acid compounds pharmaceutical compositions comprising same and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds |
US6958330B1 (en) | 1998-06-22 | 2005-10-25 | Elan Pharmaceuticals, Inc. | Polycyclic α-amino-ε-caprolactams and related compounds |
US6509331B1 (en) | 1998-06-22 | 2003-01-21 | Elan Pharmaceuticals, Inc. | Deoxyamino acid compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds |
US6552013B1 (en) | 1998-06-22 | 2003-04-22 | Elan Pharmaceuticals, Inc. | Deoxyamino acid compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds |
HRP990246A2 (en) * | 1998-08-07 | 2000-06-30 | Du Pont Pharm Co | Succinoylamino benzodiazepines as inhibitors of a beta protein production |
NZ525513A (en) * | 1998-08-07 | 2004-09-24 | Pont Pharmaceuticals Du | Succinoylamino lactams as inhibitors of Abeta protein production |
AU2003203805B8 (en) * | 1998-08-07 | 2007-02-15 | Bristol-Myers Squibb Pharma Company | Succinoylamino lactams as inhibitors of ABeta protein production |
AU1618000A (en) * | 1998-11-12 | 2000-05-29 | Du Pont Pharmaceuticals Company | Use of radioligands to screen inhibitors of amyloid-beta peptide production |
US6737038B1 (en) * | 1998-11-12 | 2004-05-18 | Bristol-Myers Squibb Company | Use of small molecule radioligands to discover inhibitors of amyloid-beta peptide production and for diagnostic imaging |
AU778005B2 (en) * | 1998-12-24 | 2004-11-11 | Bristol-Myers Squibb Pharma Company | Succinoylamino benzodiazepines as inhibitors of Abeta protein production |
EP1150976B1 (en) * | 1998-12-31 | 2003-02-26 | Aventis Pharmaceuticals Inc. | 3-(thio-substituted amido)-lactams useful as inhibitors of matrix metalloproteinase |
AU1836900A (en) * | 1998-12-31 | 2000-07-24 | Aventis Pharmaceuticals Inc. | N-carboxymethyl substituted benzolactams as inhibitors of matrix metalloproteinase |
US6262080B1 (en) * | 1998-12-31 | 2001-07-17 | Avantis Pharmaceuticals Inc. | 3-(thio-substitutedamido)-lactams useful as inhibitors of matrix metalloproteinase |
US6344450B1 (en) | 1999-02-09 | 2002-02-05 | Bristol-Myers Squibb Company | Lactam compounds and their use as inhibitors of serine proteases and method |
EP1175405A4 (en) * | 1999-02-09 | 2002-05-15 | Bristol Myers Squibb Co | LACTAM INHIBITORS OF FACTOR Xa AND ASSOCIATED METHOD |
WO2000047207A1 (en) | 1999-02-09 | 2000-08-17 | Bristol-Myers Squibb Company | LACTAM INHIBITORS OF FXa AND METHOD |
GB9929527D0 (en) * | 1999-12-14 | 2000-02-09 | Smithkline Beecham Plc | Novel compounds |
US6509330B2 (en) * | 2000-02-17 | 2003-01-21 | Bristol-Myers Squibb Company | Hydroxamic acid containing compounds useful as ACE inhibitors and/or NEP inhibotors |
WO2001060826A2 (en) * | 2000-02-17 | 2001-08-23 | Bristol-Myers Squibb Pharma Company | SUCCINOYLAMINO CARBOCYCLES AND HETEROCYCLES AS INHIBITORS OF Aβ PROTEIN PRODUCTION |
MXPA02009755A (es) * | 2000-04-03 | 2003-03-27 | Bristol Myers Squibb Pharma Co | Lactamas ciclicas como inhibidores de la produccion de proteina a-beta. |
AU2001257006A1 (en) | 2000-04-11 | 2001-10-23 | Du Pont Pharmaceuticals Company | Substituted lactams as inhibitors of abeta protein production |
WO2001085716A1 (en) * | 2000-05-11 | 2001-11-15 | Kyowa Hakko Kogyo Co., Ltd | 2-piperidone compounds for the treatment of cancer |
US6878363B2 (en) | 2000-05-17 | 2005-04-12 | Bristol-Myers Squibb Pharma Company | Use of small molecule radioligands to discover inhibitors of amyloid-beta peptide production and for diagnostic imaging |
IL147629A0 (en) | 2000-06-01 | 2002-08-14 | Bristol Myers Squibb Pharma Co | LACTAMS SUBSTITUTED BY CYCLIC SUCCINATES AS INHIBITORS OF Aβ PROTEIN PRODUCTION |
US8283135B2 (en) | 2000-06-30 | 2012-10-09 | The Procter & Gamble Company | Oral care compositions containing combinations of anti-bacterial and host-response modulating agents |
AU2001271544A1 (en) * | 2000-06-30 | 2002-01-14 | The Procter And Gamble Company | Oral compositions comprising host-response modulating agent |
ATE401089T1 (de) * | 2000-06-30 | 2008-08-15 | Procter & Gamble | Orale zubereitungen, die antimikrobielle wirkstoffe enthalten zur prävention von systemischen erkrankungen |
US6511973B2 (en) | 2000-08-02 | 2003-01-28 | Bristol-Myers Squibb Co. | Lactam inhibitors of FXa and method |
WO2003033018A1 (en) * | 2001-10-18 | 2003-04-24 | Warner-Lambert Company Llc | Method for preparing purified matrix metalloproteinase |
CA2511521C (en) | 2002-12-30 | 2012-02-07 | Angiotech International Ag | Drug delivery from rapid gelling polymer composition |
US20050192265A1 (en) * | 2003-03-20 | 2005-09-01 | Thompson Richard C. | Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds |
KR101155335B1 (ko) * | 2005-01-07 | 2012-06-11 | 엘지전자 주식회사 | 이동통신 단말기의 멀티미디어 메시지 동작방법 |
Family Cites Families (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4743587A (en) * | 1985-09-10 | 1988-05-10 | G. D. Searle & Co. | Hydroxamic acid based collagenase inhibitors |
US4771038A (en) * | 1986-01-21 | 1988-09-13 | Ici Americas Inc. | Hydroxamic acids |
GB8601368D0 (en) * | 1986-01-21 | 1986-02-26 | Ici America Inc | Hydroxamic acids |
DK77487A (da) * | 1986-03-11 | 1987-09-12 | Hoffmann La Roche | Hydroxylaminderivater |
FR2609289B1 (fr) * | 1987-01-06 | 1991-03-29 | Bellon Labor Sa Roger | Nouveaux composes a activite d'inhibiteurs de collagenase, procede pour les preparer et compositions pharmaceutiques contenant ces composes |
CA2002021A1 (en) * | 1988-11-03 | 1990-05-03 | Ann E. Aulabaugh | Inhibition of ketol-acid reductoisomerase by oxalylhydroxamate derivatives |
GB8827308D0 (en) * | 1988-11-23 | 1988-12-29 | British Bio Technology | Compounds |
GB8827305D0 (en) * | 1988-11-23 | 1988-12-29 | British Bio Technology | Compounds |
GB8919251D0 (en) * | 1989-08-24 | 1989-10-04 | British Bio Technology | Compounds |
CA2072018A1 (en) * | 1989-12-16 | 1991-06-17 | Colin Bennion | Pharmacologically active amide carboxylate derivatives |
US5075302A (en) * | 1990-03-09 | 1991-12-24 | Schering Corporation | Mercaptoacyl aminolactam endopeptidase inhibitors |
JPH04217950A (ja) * | 1990-03-28 | 1992-08-07 | Asahi Chem Ind Co Ltd | ヒドロキサム酸誘導体および酵素阻害剤ならびに抗潰瘍剤 |
DE4011172A1 (de) * | 1990-04-06 | 1991-10-10 | Degussa | Verbindungen zur bekaempfung von pflanzenkrankheiten |
US5239078A (en) * | 1990-11-21 | 1993-08-24 | Glycomed Incorporated | Matrix metalloprotease inhibitors |
US5183900A (en) * | 1990-11-21 | 1993-02-02 | Galardy Richard E | Matrix metalloprotease inhibitors |
US5189178A (en) * | 1990-11-21 | 1993-02-23 | Galardy Richard E | Matrix metalloprotease inhibitors |
GB9102635D0 (en) * | 1991-02-07 | 1991-03-27 | British Bio Technology | Compounds |
GB9107368D0 (en) * | 1991-04-08 | 1991-05-22 | Smithkline Beecham Plc | Novel compounds |
IL98681A (en) * | 1991-06-30 | 1997-06-10 | Yeda Rehovot And Dev Company L | Pharmaceutical compositions comprising hydroxamate derivatives for iron removal from mammalian cells and from pathogenic organisms and some novel hydroxamate derivatives |
DE4127842A1 (de) * | 1991-08-22 | 1993-02-25 | Rhone Poulenc Rorer Gmbh | 5-((omega)-arylalky)-2-thienyl alkansaeuren, ihre salze und/oder ihre derivate |
JPH05125029A (ja) * | 1991-11-06 | 1993-05-21 | Yamanouchi Pharmaceut Co Ltd | 新規なアミド化合物又はその塩 |
NZ249202A (en) * | 1992-02-20 | 1996-06-25 | Black James Foundation | Bicyclo[2.2.2.]octane derivatives, preparation and pharmaceutical compositions thereof |
US5525629A (en) * | 1992-04-07 | 1996-06-11 | British Bio-Technology Limited | Inhibition of cytokine production |
WO1993021942A2 (en) * | 1992-05-01 | 1993-11-11 | British Biotech Pharmaceuticals Limited | Use of mmp inhibitors |
AU666727B2 (en) * | 1992-06-25 | 1996-02-22 | F. Hoffmann-La Roche Ag | Hydroxamic acid derivatives |
GB9215665D0 (en) * | 1992-07-23 | 1992-09-09 | British Bio Technology | Compounds |
GB9223904D0 (en) * | 1992-11-13 | 1993-01-06 | British Bio Technology | Inhibition of cytokine production |
WO1994021612A1 (en) * | 1993-03-18 | 1994-09-29 | Otsuka Pharmaceutical Co., Ltd. | Carbostyril derivatives as matrix metalloproteinases inhibitors |
-
1995
- 1995-03-21 US US08/407,839 patent/US5672598A/en not_active Expired - Fee Related
-
1996
- 1996-03-18 IL IL11752796A patent/IL117527A/xx not_active IP Right Cessation
- 1996-03-19 KR KR1019970706554A patent/KR19980703151A/ko active IP Right Grant
- 1996-03-19 AU AU52558/96A patent/AU711889B2/en not_active Ceased
- 1996-03-19 WO PCT/US1996/003726 patent/WO1996029313A1/en active IP Right Grant
- 1996-03-19 AT AT96908856T patent/ATE248150T1/de not_active IP Right Cessation
- 1996-03-19 CZ CZ972951A patent/CZ295197A3/cs unknown
- 1996-03-19 CA CA002216129A patent/CA2216129C/en not_active Expired - Fee Related
- 1996-03-19 JP JP8528560A patent/JPH11502523A/ja not_active Withdrawn
- 1996-03-19 EP EP96908856A patent/EP0815084B1/en not_active Expired - Lifetime
- 1996-03-19 BR BR9607772A patent/BR9607772A/pt not_active Application Discontinuation
- 1996-03-19 DE DE69629670T patent/DE69629670T2/de not_active Expired - Fee Related
- 1996-03-19 NZ NZ304689A patent/NZ304689A/xx unknown
- 1996-03-19 HU HU9800813A patent/HUP9800813A3/hu unknown
- 1996-03-20 ZA ZA962253A patent/ZA962253B/xx unknown
- 1996-03-21 AR ARP960101859A patent/AR002718A1/es unknown
-
1997
- 1997-09-19 NO NO974335A patent/NO974335L/no unknown
Also Published As
Publication number | Publication date |
---|---|
EP0815084B1 (en) | 2003-08-27 |
NO974335D0 (no) | 1997-09-19 |
DE69629670D1 (de) | 2003-10-02 |
DE69629670T2 (de) | 2004-06-17 |
WO1996029313A1 (en) | 1996-09-26 |
NZ304689A (en) | 1999-05-28 |
US5672598A (en) | 1997-09-30 |
ZA962253B (en) | 1996-09-30 |
BR9607772A (pt) | 1998-07-07 |
HUP9800813A3 (en) | 1998-09-28 |
HUP9800813A2 (hu) | 1998-07-28 |
CA2216129A1 (en) | 1996-09-26 |
IL117527A (en) | 1999-12-22 |
EP0815084A1 (en) | 1998-01-07 |
CZ295197A3 (cs) | 1998-05-13 |
AU5255896A (en) | 1996-10-08 |
ATE248150T1 (de) | 2003-09-15 |
AR002718A1 (es) | 1998-04-29 |
CA2216129C (en) | 2002-08-20 |
MX9707214A (es) | 1997-11-29 |
AU711889B2 (en) | 1999-10-21 |
KR19980703151A (ko) | 1998-10-15 |
IL117527A0 (en) | 1996-07-23 |
JPH11502523A (ja) | 1999-03-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO974335L (no) | Laktam-holdige hydroksaminsyrederivater, deres fremstilling og deres anvendelse som inhibitorer for matriksmetallprotease | |
AP1541A (en) | New thiadazoles and oxadiazoles and their use as phosphodiesterase - 7 inhibitors. | |
CA2367017A1 (en) | Inhibitors of impdh enzyme | |
HUP0201088A2 (hu) | Új alfa-aminosav-szulfonil-vegyületek, eljárás előállításukra és ilyen vegyületeket tartalmazó gyógyászati készítmények | |
NZ514981A (en) | Renin inhibitors | |
YU84603A (sh) | Novi inhibitori tirozin kinaze | |
MY146669A (en) | Pyrazole derivatives for treating hiv | |
MXPA04000328A (es) | Derivados de alfa-hidroxiamida estatina para tratamiento de enfermedad de alzheimer. | |
TNSN04017A1 (en) | N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds | |
CA2446939A1 (en) | Pyridylpyrimidine derivatives as effective compounds against prion diseases | |
UY25679A1 (es) | Derivados de quinolin-2-ona inhibidores de la farnesil proteína transferasa útiles como agentes contra el cáncer | |
TW200512195A (en) | Benzamide 2-hydroxy-3-diaminoalkanes | |
HK1074794A1 (en) | The use of substituted cyanopyrrolidines for treating hyperlipidemia | |
MXPA04002785A (es) | Aminas sustituidas para tratamiento de enfermedad de alzheimer. | |
ZA200408283B (en) | 7-aryl-3,9-diazabicyclo (3.3.1)non-6-ene derivatives and their use as renin inhibitors in the treatment of hypertension, cardivascular or rental diseases | |
EP1396493A4 (en) | HETEROCYCLIC COMPOUNDS | |
AU7517400A (en) | N-substituted 4-aminopteridines, synthesis and use thereof as pharmaceutical agent | |
TR200102524T2 (tr) | Dihetero sübstitüe edilmiş metaloproteaz inhibitörleri. | |
MXPA03011466A (es) | Macrociclos utiles en tratamiento de enfermedades de alzheimer. | |
JP2009515915A (ja) | 炎症性疾患および他の疾患の治療のためのプロドラッグとしての新規なペプチダーゼ二重阻害剤 | |
DE60211746D1 (de) | Aminosäurederivate zur behandlung der alzheimer-krankheit | |
ATE219085T1 (de) | 2-beta-substituierte-6-alkylidenpenizillansäure derivate als beta-laktamase inhibitoren | |
NO20053726L (no) | Forbindelser med prolyloligopeptidase-hemmende aktivitet | |
MXPA04000485A (es) | Uso de acidos aril o heteroaril hidroxamicos de sulfonilo y derivados de los mismos como inhibidores de agrecanasa. | |
WO2013056079A1 (en) | High affinity beta lactamase inhibitors |